5.41
5.41 (0.82%)
As of Feb 09, 2023
Durect Corp [DRRX]
Source:
Company Overview
We are a biopharmaceutical company advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program.DUR928, a new chemical entity in clinical development, is the lead candidate in our Epigenetic Regulator Program.An endogenous, orally bioavailable small molecule, DUR-928 has been shown in preclinical studies to play an important regulatory role in lipid homeostasis, inflammation, and cell survival.
Country | United States |
Headquarters | cupertino, california |
Phone Number | 4087771417 |
Industry | manufacturing |
CEO | James E. Brown |
Website | www.posimir.com |